Ganglion Plexus Ablation in Persistent Atrial Fibrillation

Status Not yet recruiting

Clinical Trial Summary

This study aims to investigate the long-term efficacy and safety of incorporating ganglionated plexus ablation into radiofrequency ablation strategies for persistent atrial fibrillation.

Clinical Trial Description

1. Study Design: The study employs a parallel-group design with a 1:1 randomization ratio. Eligible patients meeting the specified criteria will be randomly assigned to either the conventional ablation group (pulmonary vein isolation + linear ablation) or the intervention group receiving additional ganglionated plexus ablation. 2. Intervention: Control Group: Conventional ablation (pulmonary vein isolation + linear ablation) Intervention Group: Conventional ablation + ganglionated plexus ablation (left superior, left inferior, right anterior, and right inferior ganglionated plexi) 3. Randomization and Sequence Generation: To ensure randomness and comparability, a computer-generated random sequence will be utilized. Specific steps include: - Pre-matching the numbers 1-50 with 50 random numbers. - Allocating each random number equally to 2 groups, with the assigned numbers representing the order of patient enrollment. - Performing the above steps using R. 5. Data Collection: Baseline data, including demographics, medical history, and laboratory parameters, will be collected at the start. Intraoperative electrophysiological and ablation-related parameters, as well as postoperative adverse events, will be documented. Follow-up data will include postoperative survival, quality of life (assessed using the Atrial Fibrillation Effect on Quality-of-Life questionnaire), dynamic electrocardiogram recordings, recurrence of atrial fibrillation or other arrhythmias, rehospitalization for arrhythmia, and medication usage. 6. Endpoints: - Primary Endpoints: Recurrence of atrial tachyarrhythmias; Echocardiographic parameters; Procedure-related adverse events - Secondary Endpoints: Atrial fibrillation burden; Radiofrequency ablation time; Patient postoperative quality of life; Healthcare resource utilization The trial's initiation date will be documented, and all procedures will be conducted at the Cardiovascular Department of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. The study will adhere to ethical guidelines and regulations, and informed consent will be obtained from all participants. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06181578
Study type	Interventional
Source	Tongji Hospital
Contact	Ning Zhou, Ph.D
Phone	+8613871249571
Email	zhouning@tjh.tjmu.edu.cn
Status	Not yet recruiting
Phase	N/A
Start date	January 1, 2024
Completion date	December 31, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03593486` - Low-Level EMF Stimulation for Paroxysmal Atrial Fibrillation	N/A
Terminated	`NCT01546207` - Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia	N/A
Active, not recruiting	`NCT06124690` - Persistent Atrial Fibrillation Without the Evidence of Low-voltage Areas	N/A
Recruiting	`NCT05251545` - Randomized Trial: High Power Short Duration Versus Ablation Index	N/A
Not yet recruiting	`NCT04780438` - Dapagliflozin to Prevent Atrial Fibrillation Recurrence After Transcatheter Pulmonary Venous Isolation.	Early Phase 1
Active, not recruiting	`NCT03695484` - Registry Evaluating AF Ablation Techniques
Recruiting	`NCT05777850` - High-Power Short-Duration Radiofrequency Ablation in Patients With Typical Atrial Flutter	N/A
Not yet recruiting	`NCT05565183` - Combined Study of ATrial Strain and Voltage by High Density Mapping in Young Patients With Atrial Fibrillation.	N/A
Recruiting	`NCT06160076` - Inflammatory Response Following " Pulsed Field Ablation " vs. Radiofrequency Ablation-2
Not yet recruiting	`NCT05575544` - Electroacupuncture Intervention in Catheter Ablation of Atrial Fibrillation	N/A
Recruiting	`NCT04678258` - Zero Fluoroscopy Voltage Guided vs. Linear CTI Ablation	N/A
Active, not recruiting	`NCT01630031` - Contact Force Sensing and Pulmonary Vein Isolation	N/A
Completed	`NCT04896424` - Vagal Response and Cardiac Autonomic Modulation. Insides From Cryoballoon Ablation	N/A
Completed	`NCT04906720` - Post-Ablation Pericarditis Reduction Study	Phase 2
Not yet recruiting	`NCT05273645` - PrOgnosis Following Esophageal fisTula formaTion in Pts Undergoing cathetER Ablation for AF Study
Completed	`NCT03140631` - Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation	Phase 4
Active, not recruiting	`NCT03514693` - Efficacy of Pulmonary Vein Isolation Alone in Patients With Persistent Atrial Fibrillation	N/A
Recruiting	`NCT03832959` - Esophageal Damage Protection During Pulmonary Vein Ablation. Pilot Study.	N/A
Not yet recruiting	`NCT05716581` - Prognostic Factors for Ablation of Atrial Fibrillation
Recruiting	`NCT04405258` - Left Atrial Posterior Wall Additional Isolation for Persistent Atrial Fibrillation Trial	Phase 4